Resources
Did you mean
Schering-Plough Corp. (563 results)
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Schering-Plough Now in the Feds' Crosshairs
- Schering-Plough Now in the Feds' CrosshairsThe Great Disappointment of EthicsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and...
- Discussion threads 2008-07-10
- Is Merck Hanging Schering Out to Dry on Vytorin?
- Is Merck Hanging Schering Out to Dry on Vytorin?VytorinPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and Merck...
- Discussion threads 2008-07-07
- How Pharma Stacks the Deck with Medical Journals
- How Pharma Stacks the Deck with Medical JournalsStatistical GymnasticsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and Merck...
- Discussion threads 2008-06-18
- Marketing Trumps Science in Vytorin Scandal
- In one of the drug industry's more revealing scandals in a while, Merck and Schering-Plough are struggling to rescue two new cholesterol drugs from evidence that they're useless at fighting heart disease and charges that the two companies deliberately sat on the bad news for roughly a year. ...
- Blog posts 2008-04-01
- AIG unit hit with bad-faith charges; Schering-Plough, Lexington disagree over interpretation of liability policy wording.(News)(American International Group Inc.)
- Byline: DOUGLAS McLEOD NEWARK, N.J.-Pharmaceutical giant Schering-Plough Corp. is leveling bad-faith charges against an American International Group Inc. unit for its alleged refusal to pay more than $21 million in product liability losses on thre Byline: DOUGLAS McLEOD NEWARK, N.J.-Pharmaceutical...
- Research articles 2005-08-08
- Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
- PHILADELPHIA -- Avid Radiopharmaceuticals, Inc. Avid, a product-focused molecular imaging company, and Bayer Schering Pharma, a world leader in the diagnostic imaging pharmaceutical field, today announced that Bayer Schering Pharma has exercised its right to license Avid's 18F-AV1/ZK compound, a molecular imaging agent that targets amyloid plaques in the brain....
- Research articles 2007-06-19
- Dyax Corp. and Bayer Schering Pharma AG Enter Into a Collaboration Agreement for Discovery of Therapeutic Antibodies
- CAMBRIDGE, Mass. -- Dyax Corp. (NASDAQ: DYAX) announced today that they have entered into an agreement with Bayer Schering Pharma AG for the discovery of therapeutic antibodies. Under the terms of this agreement, Dyax will identify therapeutic antibodies for two targets provided by Bayer Schering Pharma. Furthermore, these research activities...
- Research articles 2007-09-05
- FTC will appeal Schering case
- The Federal Trade Commission FTC has stated that it would appeal a decision by a federal administrative law judge who dismissed charges that Schering-- Plough and Upsher-Smith used a lawsuit settlement to illegally keep generic versions of K-Dur off the market.
- Research articles 2002-08-01
- Clarinex approval sets FDA precedent
- Mo. The FDA's approval of Schering's Clarinex desloratadine on December 21 for "the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older" broke an internal policy precedent by being based not on an FDA preapproval inspection of the plant that...
- Research articles 2002-02-01
- Schering sells MyHealth.com; Aventis adds to MyDocOnline
- Schering-Plough Corp. has sold its MyHealth Web site to Flow Management Technologies, which had built and hosted the site, reportedly to avoid conflict of interest accusations.
- Research articles 2002-10-01
- FDA examines Schering 'grass roots' coalitions
- The FDA says it will examine Schering's role in a "grass-roots" educational program on hepatitis C that was portrayed in a Washington Post expose as "a carefully orchestrated marketing campaign ... to sell the primary therapy for hepatitis C, Rebetron." The Post's article raised a few eyebrows at the FDA,...
- Research articles 2000-11-01
- Schering CEO pessimistic about FDA woes
- While reporting that the company has already spent $60 million on quality-- related and drug validation projects, Schering-Plough CEO Richard Kogan told financial analysts on June 28 that there is more to be done to get its GMP troubles in order. "We are working through our priorities, believe we are...
- Research articles 2001-08-01
- Aggressive strategy helps propel Claritin to top slot; Schering fuffles feathers as it pushes limits on guidelines.(Schering-Plough Corp.)(Brief Article)
- Schering ruffles feathers as it pushes limits on guidelines Schering ruffles feathers as it pushes limits on guidelines
- Research articles 1998-03-16
- Schering Seeks to Buy Mitsui Pharmaceuticals.(Brief Article)(Statistical Data Included)
- BERLIN, GERMANY-BASED Schering AG is in talks with Mitsui Chemicals to buy Mitsui Pharmaceuticals Inc. Mitsui Chemicals holds an 82 percent stake in the drug company. A Schering spokesperson emphasizes that the purchase is still only in the discuss BERLIN, GERMANY-BASED Schering AG is...
- Research articles 1999-12-20
- Schering Agrees to Take Aventis Stake.(Brief Article)
- SCHERING HAS REMOVED a potential obstacle to the creation of Aventis, the merger of Hoechst and Rhone-Poulenc, by agreeing to take a 24 percent stake in the new company's combined crop-protection operation. The remaining 76 percent interest i ...
- Research articles 1999-03-08
- FTC settles with AHP on generics complaint. (News).(Federal Trade commission Announces American Home Products settlement in agreement with Schering-Plough)(Brief Article)
- THE FEDERAL TRADE Commission FTC announced a settlement last week with American Home Products AHP that would resolve charges that the company entered into an anticompetitive agreement with Schering-Plough to delay the entry of a lower-cost gene THE FEDERAL TRADE Commission FTC announced a...
- Research articles 2002-02-25
- Schering's CEO, a Failed Trial and $16 Million
- Forbes' Matthew Herper and Michael Maiello have just jumped on a subject we alluded to -- perhaps too obliquely -- a few weeks back in discussing the eye-popping $30 million Schering-Plough CEO Fred Hassan pulled down in 2007. Not only did Schering post a $1.5 billion loss that year, it...
- Blog posts 2008-05-20
- Fred Hassan, Schering's $30 Million Man
- Schering-Plough has had a fairly miserable year so far, thanks to its apparent efforts to keep bad scientific news about the cholesterol pill Vytorin out of the public eye. CEO Fred Hassan, however, is still living off last year's glory -- even if it might well have been far less...
- Blog posts 2008-04-24
- Is Merck Hanging Schering Out to Dry on Vytorin?
- A close reading of the Merck and Schering-Plough first-quarter conference calls suggests that Merck is distancing itself from its joint-venture partner -- who is, in any event, in a much worse position to weather the storm over their cholesterol-fighting pill Vytorin. Vytorin, of course, is a combination...
- Blog posts 2008-04-23
- Marketing Trumps Science in Vytorin Scandal
- In one of the drug industry's more revealing scandals in a while, Merck and Schering-Plough are struggling to rescue two new cholesterol drugs from evidence that they're useless at fighting heart disease and charges that the two companies deliberately sat on the bad news for roughly a year. ...
- Blog posts 2008-04-01
- << Previous
- page 1 of 2
- Next >>
Refining Tags
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
- Hardware problem. Software problem. With AT&T Tech Support 360, at least it's not your problem.
-
With AT&T Tech Support 360, you'll have certified, U.S. based technicians on call 24/7 to help keep your computers, connections, software and peripherals up to speed for just 82¢ a day.
- Reduce computer downtime. Click to learn more.
